Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

NCT00847171 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: allogeneic GM-CSF-secreting breast cancer vaccine
BIOLOGICAL: trastuzumab
DRUG: cyclophosphamide
OTHER: flow cytometry
OTHER: immunoenzyme technique
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: biopsy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]